journal article·2023-04

DNA Nanoclusters Combined with One‐Shot Radiotherapy Augment Cancer Immunotherapy Efficiency

Yuexia Xie, Huishan Li, Lei Xu, Hanbing Zou, Xingang Wang, Xiaozhen He, Qianyun Tang, Yan Zhou, Xue Zhao, Xiaojing Chen, Hongmei Liu, Jun Pu, Dan Luo, Peifeng Liu

Advanced Materials· Volume 35· Issue 17
Publisher page

Abstract

Abstract Immunotherapy shows immense promise for improving cancer treatment. Combining immunotherapy with radiotherapy provides a conspicuous advantage due to its enhanced abscopal effect. However, established immune tolerance mechanisms in the tumor microenvironment can hamper the generation of a sufficient abscopal effect. Herein, a type of DNA nanocluster (DNAnc) that is self‐assembled by a CpG‐ODNs‐loaded Y‐shaped double‐stranded DNA vector based on the unique complementary base‐pairing rules is designed. The unique structure of DNAnc makes it load more than ≈8125.5 ± 822.5 copies of CpG ODNs within one single nanostructure, which effectively increases resistance to nuclease degradation and elevates the efficiency of repolarizing macrophages to an M1‐like phenotype. Mechanistic studies reveal that more DNAncs are endocytosed by macrophages in the cancer tissue and repolarized macrophages to elicit a robust abscopal effect with the accumulation of macrophages induced by radiotherapy, generating potent, long‐term, and durable antitumor immunity for the inhibition of tumor metastasis and the prevention of tumor recurrence, which provides a novel strategy to boost cancer immunotherapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Oncogenes and Related Genes Shanghai Cancer Institute Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200032 China

Central Laboratory Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200127 China

Micro‐Nano Research and Diagnosis Center Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200127 China

Department of Radiation Oncology Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200127 China

Department of Biological and Environmental Engineering Cornell University Ithaca NY 14853 USA

Funding

National Natural Science Foundation of China

References (48)

Show source-provided references
1. 10.1002/adma.20200763010.1002/adma.202007630 ↗
2. 10.1002/adma.20180222810.1002/adma.201802228 ↗
3. 10.1038/nrc.2018.610.1038/nrc.2018.6 ↗
4. 10.1039/C9CS00271E10.1039/C9CS00271E ↗
5. 10.1016/j.cmet.2019.06.00110.1016/j.cmet.2019.06.001 ↗
6. 10.1002/smll.20160128210.1002/smll.201601282 ↗
7. 10.1038/s41572-020-00240-310.1038/s41572-020-00240-3 ↗
8. 10.3322/caac.2166010.3322/caac.21660 ↗
9. 10.14218/JCTH.2018.0006010.14218/JCTH.2018.00060 ↗
10. 10.1016/0305-7372(89)90003-010.1016/0305-7372(89)90003-0 ↗
11. M. C.Roach G. M. M.Videtic J. D.Bradley on behalf of the IASLC Advanced Radiation Technology Committee J. Thorac. Oncol.2015 10 1261.10.1097/JTO.0000000000000610 ↗
12. 10.1016/j.radonc.2021.07.02210.1016/j.radonc.2021.07.022 ↗
13. 10.1007/s00262-021-03036-w10.1007/s00262-021-03036-w ↗
14. 10.3322/caac.2135810.3322/caac.21358 ↗
15. 10.1093/carcin/bgw00710.1093/carcin/bgw007 ↗
16. 10.1136/jitc-2020-00066710.1136/jitc-2020-000667 ↗
17. 10.3389/fimmu.2017.0082810.3389/fimmu.2017.00828 ↗
18. 10.1172/JCI8340410.1172/JCI83404 ↗
19. 10.1155/2013/73102310.1155/2013/731023 ↗
20. 10.3390/ijms2213699510.3390/ijms22136995 ↗
21. 10.1158/0008-5472.CAN-17-362310.1158/0008-5472.CAN-17-3623 ↗
22. 10.1146/annurev.immunol.20.100301.06484210.1146/annurev.immunol.20.100301.064842 ↗
23. 10.1128/JVI.00222-1610.1128/JVI.00222-16 ↗
24. 10.1016/j.immuni.2017.02.01610.1016/j.immuni.2017.02.016 ↗
25. 10.1002/adma.20150623210.1002/adma.201506232 ↗
26. 10.1126/scitranslmed.300790910.1126/scitranslmed.3007909 ↗
27. 10.1038/nri132910.1038/nri1329 ↗
28. 10.1016/j.addr.2008.12.00810.1016/j.addr.2008.12.008 ↗
29. 10.1007/s00262-019-02320-010.1007/s00262-019-02320-0 ↗
30. 10.1200/JCO.2007.12.580710.1200/JCO.2007.12.5807 ↗
31. 10.1002/cncr.2447310.1002/cncr.24473 ↗
32. 10.3390/vaccines704016610.3390/vaccines7040166 ↗
33. 10.2217/imt.12.14810.2217/imt.12.148 ↗
34. 10.1016/S1367-5931(98)80129-410.1016/S1367-5931(98)80129-4 ↗
35. 10.1021/acs.chemrev.0c0029410.1021/acs.chemrev.0c00294 ↗
36. 10.1038/nmat241910.1038/nmat2419 ↗
37. 10.1021/jacs.9b1140710.1021/jacs.9b11407 ↗
38. 10.1002/adma.20130117510.1002/adma.201301175 ↗
39. 10.1021/acsami.7b0160410.1021/acsami.7b01604 ↗
40. 10.1038/nbt110610.1038/nbt1106 ↗
41. 10.1002/anie.20090155510.1002/anie.200901555 ↗
42. 10.1002/marc.20090087210.1002/marc.200900872 ↗
43. 10.1002/smll.20100075210.1002/smll.201000752 ↗
44. 10.1002/anie.20190934510.1002/anie.201909345 ↗
45. 10.1002/anie.20180119510.1002/anie.201801195 ↗
46. 10.1038/s41590-022-01267-210.1038/s41590-022-01267-2 ↗
47. 10.1038/s41577-019-0210-z10.1038/s41577-019-0210-z ↗
48. 10.1016/j.radonc.2019.11.02010.1016/j.radonc.2019.11.020 ↗